Ghost Tree Capital’s Satsuma Pharmaceuticals STSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-473,562
Closed -$1.8M – 49
2022
Q1
$1.8M Sell
473,562
-430,663
-48% -$1.94M 0.39% 35
2021
Q4
$4.07M Hold
904,225
– – 1.46% 28
2021
Q3
$4.21M Hold
904,225
– – 1.23% 31
2021
Q2
$6.38M Hold
904,225
– – 1.75% 20
2021
Q1
$5.14M Buy
904,225
+704,225
+352% +$4.27M 1.21% 26
2020
Q4
$922K Hold
200,000
– – 0.21% 42
2020
Q3
$778K Sell
200,000
-140,000
-41% -$2.81M 0.22% 41
2020
Q2
$9.8M Buy
340,000
+225,000
+196% +$5.21M 2.58% 15
2020
Q1
$2.48M Buy
+115,000
New +$2.61M 0.66% 32

Other funds holding STSA

Ghost Tree Capital's STSA Position: Q2 2022 in Review

Ghost Tree Capital sold out of Satsuma Pharmaceuticals (STSA) in Q2 2022, closing a stake of 473,562 shares — an estimated $1.8M sold.

Ghost Tree Capital first reported a position in STSA in Q1 2020 and held it in 9 quarters. The position peaked at $9.8M in Q2 2020. 32 funds tracked by Wall St. Rank hold STSA as of Q2 2022.

  • Ghost Tree Capital reported no remaining Satsuma Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Ghost Tree Capital sold 473,562 Satsuma Pharmaceuticals shares in Q2 2022, an estimated $1.8M.
  • Ghost Tree Capital first reported a position in Satsuma Pharmaceuticals in Q1 2020 and held it in 9 quarters.
  • Ghost Tree Capital's Satsuma Pharmaceuticals position peaked at $9.8M in Q2 2020.
  • 32 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q2 2022.

Based on Ghost Tree Capital's 13F filing for Q2 2022, filed 15 Aug 2022.